跳至主要内容
临床试验/NCT00166894
NCT00166894Unknown不适用

Evaluation of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) as a Diagnostic Tool for Patients With Pleural Effusion

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2005年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1

研究概览

简要总结

The aim of this trial is to evaluate the level of TREM-1 in different kinds of pleural effusion.

详细描述

The triggering receptor expressed on myeloid cells-1 (TREM-1) is a member of the immunoglobulin superfamily, and its expression is upregulated on phagocytic cells in the presence of bacteria or fungi. Several experiments by Bouchon and colleagues showed that TREM-1 mediates the acute inflammatory response to microbial products. Human tissues infected with bacteria are infiltrated with neutrophils and macrophages that express high levels of TREM-1. Conversely, TREM-1 is only weakly expressed in samples from patients with noninfectious inflammatory disorders. In addition, TREM-1 is shed from the membrane of activated phagocytes and can be found in a soluble form in body fluids. The presence of a soluble form of TREM-1 in samples of bronchoalveolar lavage fluid from mechanically ventilated patients has been shown to be a good indicator of infectious pneumonia.

研究设计

研究类型
Observational
观察模型
Natural History
时间视角
Other

入排标准

年龄范围
18 Minutes 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of pleural effusion
  • Pleural effusion proved by chest sonography

排除标准

  • Conditions for which thoracentesis are contraindicated
  • Pregnancy

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Use of the Triggering Receptor Expressed on Myeloid... | 临床试验